Health

GSK to lower prices to woo India mkt

CEO Says Pharma Major Plans To Invest Rs 430 Cr To Develop Vaccines Here

GLAXOSMITHKLINE (GSK) would cut retail prices in India to cater to the lower-income segment besides pumping in Rs 430 crore to develop vaccines from its local facilities, according to Andrew Witty, global CEO of the world

Publication Date: 
10/03/2010
Economic Times (New Delhi)
Tags:
Drugs, Drug Industry, Vaccination, Patents, India
Health

Clinical trials come out of closet in India

New Delhi: Clinical trials in India are finally becoming transparent. There has been a dramatic increase in the number of trials that have got officially registered in Clinical Trials Registry-India (CTRI).

Publication Date: 
09/03/2010
Times Of India (New Delhi)
Tags:
Health, Medical Research, Drug Industry, Indian Council Of Medical Research (ICMR), India
Health

Prices of new pharmaceuticals in India: A cross section study

There is an ongoing debate about the rationality of price controls in a regime where drugs can be manufactured through alternative processes as was the case in India before 2005. In a regime of only process patents, competition was expected to bring prices down.

Publication Date: 
06/03/2010
Ravinder Jha
Economic and Political Weekly
45
10
71
Tags:
Health, Drugs, Drug Industry, Patents, India
Health

Ranbaxys failure to get USFDA nod to hurt co

RANBAXY Laboratories

Publication Date: 
03/03/2010
Economic Times (New Delhi)
Tags:
Health, Health Care, Drugs, Drug Industry, Patents, Japan, India, Ranbaxy Pharmaceuticals
Health

No interim stay on Ciplas Nexavar clone

THE Supreme Court (SC) on Friday turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer

Publication Date: 
01/03/2010
Economic Times (New Delhi)
Tags:
Health, Health Care, Drugs, Drug Industry, Supreme Court, India
Health

High hopes for oral cholera vaccine

A trial of a new oral cholera vaccine in Kolkata is promising but, as Patralekha Chatterjee reports, a vaccine is only one weapon
in the battle against the disease.

Publication Date: 
01/03/2010
Patralekha Chatterjee
Bulletin of the World Health Organization
88
3
165
Tags:
Waterborne diseases, Health, Slums, Medical Research, Drugs, Drug Industry, Vaccination, Cholera, India, Calcutta (D)
Health

Gifted doctors

Can the Medical Council of India effectively end the practice of drug companies giving freebies to doctors? (Editorial)

Publication Date: 
01/03/2010
Economic and Political Weekly
45
15
9
Tags:
Health, Health Personnel, Drug Industry, India
Health

The Medical Council of India guidelines on industryphysician relationship: Breaking the conspiracy of silence

The Medical Council of India (MCI) in an amendment to its existing code of conduct, the Indian Medical Council (professional conduct, etiquette and ethics) regulations 2002, has proposed sweeping guidelines on the relationship between the pharmaceutical industry and the medical profession in India. (Editorial)

Publication Date: 
28/02/2010
Sanjay Nagral, Nobhojit Roy
National Medical Journal of India
23
2
69
Tags:
Health, Health Personnel, India, Drug Industry
Health

Trials of new drug offer hope to cancer patients

For the melanoma patients who signed on to try a drug known as PLX4032, the clinical trial was a last resort. Their bodies were riddled with tumours, leaving them barely months to live.

Publication Date: 
24/02/2010
Times Of India (New Delhi)
Tags:
Cancer, Health, Health Care, Drugs, Drug Industry, India
Health

Experts stress on clinical trials for new drugs

The 28th national workshop on clinical pharmacology, organised by the Department of Pharmacology, PGIMER, Chandigarh, began on Monday. Nearly 65 delegates from across the country and Nepal are participating in the weeklong workshop.

Publication Date: 
24/02/2010
Indian Express (Chandigarh)
Tags:
Health, Health Care, Drugs, Drug Industry, Chandigarh

Pages